Article
Treatment of irritant contact dermatitis in healthcare settings during the COVID19…
medRxiv: the preprint server for health sciences · 2021 · Christine T. Styles, author Michael Vanden Oever, author Jonathan Brown, author Sweta Rai, author Sarah Walsh, author Finola M. Ryan, author Wendy S. Barclay, author Rachel S. Edgar, author
Key facts
| Title | Treatment of irritant contact dermatitis in healthcare settings during the COVID19 pandemic: The emollient Dermol 500 exhibits virucidal activity against influenza A virus and SARS-CoV-2 |
|---|---|
| First author | Christine T. Styles, author Michael Vanden Oever, author Jonathan Brown, author Sweta Rai, author Sarah Walsh, author Finola M. Ryan, author Wendy S. Barclay, author Rachel S. Edgar, author |
| Journal | medRxiv : the preprint server for health sciences |
| Published | Feb 17, 2021 |
| DOI | 10.1101/2021.02.12.21251419 |
| Devices mentioned | BK110039, DEN000008, K022086 |
| Product codes mentioned | JCI, KIP, KIT, MVU, NDS, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1